Depression in MS Patients Raises Risk of Vascular Disease and Death & COVID-19 Booster Shot

Nov 12, 2021, 12:00 AM

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how a study found MS and depression doubled patients' vascular disease risk over 10 years, and relative to controls greatly raised risk of death.
Also, Price Wooldridge, reads “I’m Grateful for My COVID-19 Booster Shot”, a column by Ed Tobias.
===================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/